Brawn Biotech

Brawn Biotech Liabilities

The The Liabilities of Brawn Biotech (530207.BO) as of Oct 9, 2026 is 171.27 M INR. In the previous year, The Liabilities was 95.24 M INR — a change of 79.83% (higher).

Liabilities

171.27 MINR

YoY

79.83%

Last updated:

In 2025, Brawn Biotech's total liabilities amounted to 171.27 M INR, a 79.83% difference from the 95.24 M INR total liabilities in the previous year.

The Brawn Biotech Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2023
82.21 M INR
Jan 1, 2024
95.24 M INR
Jan 1, 2025
171.27 M INR
The Brawn Biotech Liabilities history
YEARLiabilitiesYoY
171.27 MINR+79.83%
95.24 MINR+15.84%
82.21 MINR—
Access this data via the Eulerpool API
Get Free API Key

Brawn Biotech Stock analysis

What does Brawn Biotech do? Brawn Biotech is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Brawn Biotech's Liabilities

Brawn Biotech's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Brawn Biotech's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Brawn Biotech's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Brawn Biotech's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Brawn Biotech’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Brawn Biotech stock

The Liabilities of Brawn Biotech is 171.27 M INR in 2025.

The Liabilities of Brawn Biotech changed from 95.24 M INR to 171.27 M INR, representing a 79.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Brawn Biotech since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Brawn Biotech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Brawn Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Brawn Biotech